Cargando…
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
OBJECTIVE: To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. DESIGN: A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. SETTING: University Hospitals Birmingham NHS Foundation Trust (UHBFT)...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462045/ https://www.ncbi.nlm.nih.gov/pubmed/32917840 http://dx.doi.org/10.1136/thoraxjnl-2020-215414 |
_version_ | 1783576844936675328 |
---|---|
author | Shields, Adrian Faustini, Sian E Perez-Toledo, Marisol Jossi, Sian Aldera, Erin Allen, Joel D Al-Taei, Saly Backhouse, Claire Bosworth, Andrew Dunbar, Lyndsey A Ebanks, Daniel Emmanuel, Beena Garvey, Mark Gray, Joanna Kidd, I Michael McGinnell, Golaleh McLoughlin, Dee E Morley, Gabriella O'Neill, Joanna Papakonstantinou, Danai Pickles, Oliver Poxon, Charlotte Richter, Megan Walker, Eloise M Wanigasooriya, Kasun Watanabe, Yasunori Whalley, Celina Zielinska, Agnieszka E Crispin, Max Wraith, David C Beggs, Andrew D Cunningham, Adam F Drayson, Mark T Richter, Alex G |
author_facet | Shields, Adrian Faustini, Sian E Perez-Toledo, Marisol Jossi, Sian Aldera, Erin Allen, Joel D Al-Taei, Saly Backhouse, Claire Bosworth, Andrew Dunbar, Lyndsey A Ebanks, Daniel Emmanuel, Beena Garvey, Mark Gray, Joanna Kidd, I Michael McGinnell, Golaleh McLoughlin, Dee E Morley, Gabriella O'Neill, Joanna Papakonstantinou, Danai Pickles, Oliver Poxon, Charlotte Richter, Megan Walker, Eloise M Wanigasooriya, Kasun Watanabe, Yasunori Whalley, Celina Zielinska, Agnieszka E Crispin, Max Wraith, David C Beggs, Andrew D Cunningham, Adam F Drayson, Mark T Richter, Alex G |
author_sort | Shields, Adrian |
collection | PubMed |
description | OBJECTIVE: To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. DESIGN: A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. SETTING: University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK. PARTICIPANTS: 545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms consistent with COVID-19. No potential participants were excluded. INTERVENTION: Participants volunteered a nasopharyngeal swab and a venous blood sample that were tested for SARS-CoV-2 RNA and anti-SARS-CoV-2 spike glycoprotein antibodies, respectively. Results were interpreted in the context of prior illnesses and the hospital departments in which participants worked. MAIN OUTCOME MEASURE: Proportion of participants demonstrating infection and positive SARS-CoV-2 serology. RESULTS: The point prevalence of SARS-CoV-2 viral carriage was 2.4% (n=13/545). The overall seroprevalence of SARS-CoV-2 antibodies was 24.4% (n=126/516). Participants who reported prior symptomatic illness had higher seroprevalence (37.5% vs 17.1%, χ(2)=21.1034, p<0.0001) and quantitatively greater antibody responses than those who had remained asymptomatic. Seroprevalence was greatest among those working in housekeeping (34.5%), acute medicine (33.3%) and general internal medicine (30.3%), with lower rates observed in participants working in intensive care (14.8%). BAME (Black, Asian and minority ethnic) ethnicity was associated with a significantly increased risk of seropositivity (OR: 1.92, 95% CI 1.14 to 3.23, p=0.01). Working on the intensive care unit was associated with a significantly lower risk of seropositivity compared with working in other areas of the hospital (OR: 0.28, 95% CI 0.09 to 0.78, p=0.02). CONCLUSIONS AND RELEVANCE: We identify differences in the occupational risk of exposure to SARS-CoV-2 between hospital departments and confirm asymptomatic seroconversion occurs in healthcare workers. Further investigation of these observations is required to inform future infection control and occupational health practices. |
format | Online Article Text |
id | pubmed-7462045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74620452020-09-03 SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study Shields, Adrian Faustini, Sian E Perez-Toledo, Marisol Jossi, Sian Aldera, Erin Allen, Joel D Al-Taei, Saly Backhouse, Claire Bosworth, Andrew Dunbar, Lyndsey A Ebanks, Daniel Emmanuel, Beena Garvey, Mark Gray, Joanna Kidd, I Michael McGinnell, Golaleh McLoughlin, Dee E Morley, Gabriella O'Neill, Joanna Papakonstantinou, Danai Pickles, Oliver Poxon, Charlotte Richter, Megan Walker, Eloise M Wanigasooriya, Kasun Watanabe, Yasunori Whalley, Celina Zielinska, Agnieszka E Crispin, Max Wraith, David C Beggs, Andrew D Cunningham, Adam F Drayson, Mark T Richter, Alex G Thorax Respiratory Infection OBJECTIVE: To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. DESIGN: A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. SETTING: University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK. PARTICIPANTS: 545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms consistent with COVID-19. No potential participants were excluded. INTERVENTION: Participants volunteered a nasopharyngeal swab and a venous blood sample that were tested for SARS-CoV-2 RNA and anti-SARS-CoV-2 spike glycoprotein antibodies, respectively. Results were interpreted in the context of prior illnesses and the hospital departments in which participants worked. MAIN OUTCOME MEASURE: Proportion of participants demonstrating infection and positive SARS-CoV-2 serology. RESULTS: The point prevalence of SARS-CoV-2 viral carriage was 2.4% (n=13/545). The overall seroprevalence of SARS-CoV-2 antibodies was 24.4% (n=126/516). Participants who reported prior symptomatic illness had higher seroprevalence (37.5% vs 17.1%, χ(2)=21.1034, p<0.0001) and quantitatively greater antibody responses than those who had remained asymptomatic. Seroprevalence was greatest among those working in housekeeping (34.5%), acute medicine (33.3%) and general internal medicine (30.3%), with lower rates observed in participants working in intensive care (14.8%). BAME (Black, Asian and minority ethnic) ethnicity was associated with a significantly increased risk of seropositivity (OR: 1.92, 95% CI 1.14 to 3.23, p=0.01). Working on the intensive care unit was associated with a significantly lower risk of seropositivity compared with working in other areas of the hospital (OR: 0.28, 95% CI 0.09 to 0.78, p=0.02). CONCLUSIONS AND RELEVANCE: We identify differences in the occupational risk of exposure to SARS-CoV-2 between hospital departments and confirm asymptomatic seroconversion occurs in healthcare workers. Further investigation of these observations is required to inform future infection control and occupational health practices. BMJ Publishing Group 2020-12 2020-09-11 /pmc/articles/PMC7462045/ /pubmed/32917840 http://dx.doi.org/10.1136/thoraxjnl-2020-215414 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Respiratory Infection Shields, Adrian Faustini, Sian E Perez-Toledo, Marisol Jossi, Sian Aldera, Erin Allen, Joel D Al-Taei, Saly Backhouse, Claire Bosworth, Andrew Dunbar, Lyndsey A Ebanks, Daniel Emmanuel, Beena Garvey, Mark Gray, Joanna Kidd, I Michael McGinnell, Golaleh McLoughlin, Dee E Morley, Gabriella O'Neill, Joanna Papakonstantinou, Danai Pickles, Oliver Poxon, Charlotte Richter, Megan Walker, Eloise M Wanigasooriya, Kasun Watanabe, Yasunori Whalley, Celina Zielinska, Agnieszka E Crispin, Max Wraith, David C Beggs, Andrew D Cunningham, Adam F Drayson, Mark T Richter, Alex G SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title | SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title_full | SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title_fullStr | SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title_full_unstemmed | SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title_short | SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
title_sort | sars-cov-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study |
topic | Respiratory Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462045/ https://www.ncbi.nlm.nih.gov/pubmed/32917840 http://dx.doi.org/10.1136/thoraxjnl-2020-215414 |
work_keys_str_mv | AT shieldsadrian sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT faustinisiane sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT pereztoledomarisol sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT jossisian sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT alderaerin sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT allenjoeld sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT altaeisaly sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT backhouseclaire sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT bosworthandrew sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT dunbarlyndseya sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT ebanksdaniel sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT emmanuelbeena sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT garveymark sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT grayjoanna sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT kiddimichael sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT mcginnellgolaleh sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT mcloughlindeee sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT morleygabriella sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT oneilljoanna sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT papakonstantinoudanai sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT picklesoliver sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT poxoncharlotte sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT richtermegan sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT walkereloisem sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT wanigasooriyakasun sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT watanabeyasunori sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT whalleycelina sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT zielinskaagnieszkae sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT crispinmax sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT wraithdavidc sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT beggsandrewd sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT cunninghamadamf sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT draysonmarkt sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy AT richteralexg sarscov2seroprevalenceandasymptomaticviralcarriageinhealthcareworkersacrosssectionalstudy |